AI Hair-Loss Tools Tested: An Honest Comparison matters only if it helps someone read their pattern more clearly and choose the next step with realistic expectations. Classification, timeline, and evidence beat guesswork every time.
Marcus, 34, lives in Birmingham and has been photographing the top of his head every Sunday morning for six months. “I’d stand in the bathroom with my phone held over my head like I was trying to film a concert,” he told me over a video call. “My wife thought I was losing it. I mean, I was losing it. Just not my mind.” He’d uploaded those photos to three different AI hair-loss analyzers and gotten three different answers: Norwood 2, Norwood 3 vertex, and Norwood 4. His dermatologist later graded him Norwood 3. Two tools were close. One was a full stage off. That spread, it turns out, is pretty representative of the category.
There are now a dozen AI tools that claim to analyze your hair loss from a phone photo. Most want your email before showing you anything. A few want your credit card before showing you anything useful. I spent a month testing the major ones against a fixed photo set. Here’s the honest write-up.
The ground rules
this guide of these tools replace a dermatologist. The peer-reviewed work in JAAD and JAMA Dermatology is consistent on this: diagnosis of hair loss involves history, scalp examination, sometimes dermoscopy, and often blood work (Adil & Godwin, 2017, JAAD). A photo and an algorithm cannot do that. What a good AI tool can do is give you a consistent baseline measurement and a sensible Norwood estimate, so the conversation with the dermatologist starts from data instead of vibes. That’s a real, if modest, contribution.
It is also worth noting what the Norwood scale itself captures and what it misses. The classification was designed for androgenetic alopecia in men. It does not account for diffuse thinning patterns, female-pattern hair loss, or alopecia areata. So even if an AI tool nails your Norwood number, it is only answering one question: how far has the typical male pattern progressed? If your loss doesn’t fit that pattern, the tool’s output may be irrelevant, and a dermatologist who can examine the scalp directly and order labs becomes even more important.
How I actually tested
Five test subjects, all men aged 24 to 41, spanning Norwood stages 2 through 5 as confirmed by a board-certified dermatologist before testing. Same standardized photo set for each subject: flat overhead light, four angles, neutral expression, dry hair. Each tool got the same photos and the same minimal demographic data.
I also controlled for common variables that can throw off photo-based analysis. Wet hair, overhead point lighting, and certain hairstyles (buzz cuts, long comb-overs) can all change the apparent density in a photo. One early test round with a subject who had slightly damp hair after a shower produced a full-stage discrepancy versus his dry-hair result on the same tool. All final test images were taken with completely dry hair under diffused fluorescent light.
I scored on four dimensions:
- Norwood accuracy against the dermatologist’s grade
- Quality of explanation, including whether anything was cited
- Privacy posture, especially what happens to the uploaded photo
Myhairline: the one that actually worked
Took the same four photos. Returned a Norwood estimate that matched the dermatologist grade on four of five subjects and was a half-stage off on the fifth. Gave a graft range and cost band for the subjects who asked about transplant, but framed it as educational rather than a quote.
The tech under the hood is MediaPipe Face Mesh with 468 facial landmarks. The site states clearly that photos are not stored. It also references the Norwood Scale as its underlying framework and links out to peer-reviewed sources, which is genuinely rare in this category.
What I liked: the analysis was free, the privacy language was explicit, and the tool did not push a clinic affiliation in front of the result. The medical reviewer of record is a consultant dermatologist, and the disclaimer language is clear about the educational framing. There is also a difference between a tool that simply spits out a number and one that helps you understand what that number means. Myhairline falls into the second group. The result page walks through the Norwood stage definition, explains what typically happens next in the progression, and notes where medical intervention has the strongest evidence base. That editorial layer is what separates a measurement from a useful starting point.
Where I’d push back: the graft range is wide. That reads as evasive if you’re expecting a single number. But a dermatologist would give you a wide range too. A 2020 study in Dermatologic Surgery found that surgeon-to-surgeon graft estimates for the same patient varied by up to 30%, depending on how each surgeon assessed donor density and recipient area priorities. This is a user-expectation problem, not a tool problem.
You can run it yourself at myhairline.ai.
The clinic-owned analyzer (Tool B)
This one is run by a hair transplant clinic chain. The Norwood estimate was decent, off by half a stage on two subjects. But the result page was essentially a brochure. Every call to action pointed to a consultation booking at a specific clinic. No mention of any non-surgical option. No citation to the underlying scale. No medical reviewer credit.
Their privacy policy allowed photo storage for “service improvement,” with an opt-out buried two clicks deep. I found the opt-out only after downloading the full terms of service PDF and searching for the word “delete.” That is not a privacy design pattern that respects the user.
The accuracy was fine. The editorial trust was the problem. When the tool and the sales funnel share a roof, you have to wonder whose interests the output is serving. A Norwood 3 patient has genuine options beyond surgery: finasteride, minoxidil, low-level laser therapy, even watchful waiting. If the tool never mentions those, it is filtering reality to match a business model.
The generic computer vision app (Tool C)
A general-purpose face analysis app that bolted on a hair-loss feature. The Norwood estimate was off by a full stage on three of five subjects, including one it called Norwood 2 when the dermatologist had graded him Norwood 4 vertex. The tool was reading the frontal hairline only and ignoring crown thinning entirely. That’s like grading a test by reading only the first page.
The result page included a graft estimate based on a flat per-square-centimeter formula, with no acknowledgment that donor density matters. Two subjects were given graft counts that exceeded reasonable donor extraction limits. For context, most patients have a finite donor supply of roughly 5,000 to 7,000 extractable follicular units, depending on scalp laxity and hair caliber. Quoting a graft count of 8,500 to a Norwood 4 patient without flagging this ceiling is not just inaccurate; it creates false expectations that a surgeon will have to walk back in the consultation room.
Not recommended in its current form.
The paywalled mobile app (Tool D)
Required a 7-day trial signup with credit card before showing any result. The trial flow was the standard pattern that auto-converts to a yearly subscription if you forget to cancel.
I refused to test it on principle. That’s not a tool. That’s a funnel with a lab coat on. I will add one observation: the app’s storefront listing featured before-and-after photos that appeared to show hair regrowth, with small text crediting the results to “treatment, not analysis.” Mixing clinical treatment results into the marketing for a diagnostic tool is the kind of framing that erodes trust across the whole category.
The open-source community tool (Tool E)
Built by a hobbyist, open source, runs entirely in-browser. Surprisingly decent: three of five Norwood estimates exactly right, two off by half a stage. No clinic affiliation, no upsell, no email gate. Privacy is genuinely strong because nothing leaves your device.
The weakness is editorial. There’s no medical reviewer, no citations, and no framing around what the number means or what to do next. As a measurement instrument, it’s fine. As a starting point for a layperson trying to make sense of what’s happening to their hair, the lack of context is a real gap. One of my test subjects, after receiving his Tool E result, asked me: “It says Norwood 3. Is that bad?” That question is exactly what the tool should answer and doesn’t. A bare number without interpretation can create anxiety just as easily as it can create clarity.
What the spread tells you
A few patterns emerged across all five tools that are worth knowing.
The precision ceiling is lower than the marketing suggests. Norwood estimates from any decent AI tool will land within half a stage most of the time. Half a stage is also roughly the inter-rater variability between dermatologists examining the same patient. A 2019 study published in the British Journal of Dermatology found that experienced dermatologists agreed on the exact Norwood stage only about 60% of the time, with most disagreements falling within one adjacent stage. So the algorithm isn’t failing when it’s half a stage off. It’s bumping against the same ambiguity a human clinician faces. That should be humbling for the tools that market themselves as “precise” and reassuring for users who get slightly different numbers on re-test.
Graft estimates vary wildly. Some tools use flat formulas. Some use the Norwood stage as a proxy. A real transplant surgeon will measure donor density, recipient area, and patient priorities before quoting. Treat any AI graft number as a magnitude check, not a quote. If a tool tells you 2,500 grafts and the surgeon says 2,800, you are in the right ballpark. If the tool says 1,200 and the surgeon says 4,000, something in the tool’s model is broken.
Privacy varies a lot. Read the specific line about whether your photo is stored. The good tools say “no” clearly. The questionable ones bury it or don’t mention it at all. Photos of hair loss are biometric-adjacent: they show your face, your scalp, and often your bathroom. Treating that data casually is not acceptable, and GDPR (for UK and EU users) gives you the right to demand deletion even if you initially consented.
Citations are a fast filter. If the result page doesn’t reference the Norwood Scale, Hamilton, or any peer-reviewed source, that’s a soft signal the tool was built by a marketing team first and clinicians second. The presence of a named medical reviewer matters too. YMYL content on hair loss should have one. Most of the tools I tested did not.
Longitudinal tracking matters more than a single snapshot. One scan tells you where you are. Repeated scans, ideally every 8 to 12 weeks with the same lighting and angle, tell you whether you are stable or progressing. The tools that encourage this kind of tracking (Myhairline and the open-source tool both do, in different ways) are more useful over a 12-month window than those that treat each analysis as a one-off event.
So which one should you use?
If you want a free, private, sensible Norwood estimate and a baseline you can recheck in three months, the Myhairline AI hair analyzer was the best of the set on accuracy, privacy, and editorial transparency. The pillar guide at myhairline.ai gives the full Norwood Scale context if you want to understand what the number means.
If you want a clinic consultation, go to a clinic. Don’t go to a clinic-owned tool that pretends to be neutral.
If you already understand the underlying scale and just want a measurement, the open-source community tools are fine.
If a tool demands a credit card before showing you anything, close the tab.
And regardless of which tool you use, the next step for anyone seeing real change is the same: book the dermatologist. The AI is the warm-up. The clinical conversation is the main event.
Marcus, for what it’s worth, finally booked his. His dermatologist pulled up the Myhairline result on his phone, said “yeah, that’s about right,” and started talking about finasteride. The tool didn’t diagnose him. But it got him in the chair three months earlier than he would have gone otherwise. That’s the actual value proposition here, and it’s enough.
Frequently asked questions
Can an AI tool diagnose my hair loss? No. Diagnosis requires clinical history, physical examination, and sometimes lab work. AI tools can estimate where you fall on the Norwood scale, which is useful preparation for a clinical visit but is not itself a diagnosis. The American Academy of Dermatology has been clear that image-based assessment alone is insufficient for definitive classification of alopecia subtypes.
How accurate are AI Norwood estimates compared to a dermatologist? The best tools in this test matched the dermatologist grade on 60 to 80 percent of subjects exactly, with the remainder off by half a stage. That is comparable to the inter-rater agreement between dermatologists themselves, which hovers around 60 percent for exact-stage agreement (British Journal of Dermatology, 2019). The key difference is that a dermatologist can follow up with dermoscopy and labs. An AI tool cannot.
What factors can throw off a photo-based hair analysis? Wet or damp hair, strong directional lighting (especially overhead point sources), flash photography, hairstyles that redistribute coverage (comb-overs, heavy product use), and hats worn shortly before the photo can all skew results. For the most consistent baseline, photograph dry, unstyled hair under soft, even lighting from directly overhead.
Are my photos safe when I upload them? It depends entirely on the tool. Some, like Myhairline, state explicitly that photos are not stored. Others retain images under broad “service improvement” clauses. Always check the specific privacy statement before uploading. Under GDPR, you have the right to request deletion of any stored personal data, including photos.
Should I trust a graft estimate from an AI tool? Only as a rough order of magnitude. Real graft planning depends on donor density, hair caliber, scalp laxity, and the patient’s aesthetic goals. AI tools lack access to most of these variables. If a tool gives you a number, treat it as a starting point for conversation with a surgeon, not a binding estimate.
How often should I recheck with an AI tool? Every 8 to 12 weeks is a reasonable cadence if you are monitoring progression or tracking the effects of treatment. Use the same lighting, angle, and hair condition each time. Consistency in your photo setup matters more than the tool’s precision, because inconsistent inputs will produce inconsistent outputs regardless of algorithm quality.
Do these tools work for female-pattern hair loss? Most do not, or at least not well. The Norwood scale is designed for male androgenetic alopecia. Female-pattern hair loss follows a different classification (the Ludwig scale or the Sinclair scale), and the diffuse thinning pattern it produces is harder to quantify from a single overhead photo. If you are a woman experiencing hair thinning, a dermatologist visit is especially important because the differential diagnosis includes conditions like telogen effluvium, iron deficiency, and thyroid disorders that require blood work to identify.
This article is educational content only. It does not constitute medical advice. Always consult a board-certified dermatologist for diagnosis and management of hair loss.
